Risk for fracture in women with low serum levels of thyroid-stimulating hormone

Annals of Internal Medicine

Volumn 134, Issue 7, 2001, Pages 561-568

  Bauer, D C ^a   Ettinger, B ^a   Nevitt, M C ^a   Stone, K L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; THYROID HORMONE; THYROTROPIN;

AGE; AGED; ARTICLE; BONE MASS; BONE MINERAL; CALCANEUS; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HIP FRACTURE; HORMONAL THERAPY; HUMAN; HYPERTHYROIDISM; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OSTEOPOROSIS; POSTMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SPINE RADIOGRAPHY; THYROID DISEASE; THYROTROPIN BLOOD LEVEL; UNITED STATES; VERTEBRA FRACTURE; BLOOD; BONE DENSITY; CASE CONTROL STUDY; CLINICAL TRIAL; ESTROGEN THERAPY; FRACTURE; MALE; MULTICENTER STUDY; SPINE FRACTURE;

AGED; BONE DENSITY; CASE-CONTROL STUDIES; ESTROGEN REPLACEMENT THERAPY; FOLLOW-UP STUDIES; FRACTURES; HIP FRACTURES; HUMAN; HYPERTHYROIDISM; MALE; POSTMENOPAUSE; PROSPECTIVE STUDIES; RISK FACTORS; SPINAL FRACTURES; SUPPORT, U.S. GOV'T, P.H.S.; THYROID HORMONES; THYROTROPIN;

EID: 0035799398     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-134-7-200104030-00009     Document Type: Article

References (52)

1. The aging thyroid. The use of thyroid hormone in older persons
2. Hyperthyroxinemia in patients receiving thyroid replacement therapy
3. Perspective. How many women have osteoporosis?
4. Risk factors for hip fracture in white women
5. Mineral and bone metabolism in thyroid disease: A review
6. Clinical guideline, part 2. Screening for thyroid disease: An update. American College of Physicians
7. Borderline-low serum thyrotropin level is correlated with increased fasting urinary hydroxyptoline excretion
8. Measurement of bone collagen degradation in hyperthyroidism and during thyroxine replacement therapy using pyridinium cross-links as specific urinary markers
9. Subclinical hyperthyroidism and reduced bone density as a possible result of prolonged suppression of the pituitary-thyroid axis with L-thyroxine
10. A therapeutic dilemma: Suppressive doses of thyroxine significantly reduce bone mineral measurements in both premenopausal and postmenopausal women with thyroid carcinoma
11. Skeletal integrity in premenopausal and postmenopausal women receiving long-term L-thyroxine therapy
12. Bone mineral density in postmenopausal women treated with L-thyroxine
13. Effect of thyroxine therapy on bone metabolism in substituted hypothyroid patients with normal or suppressed levels of TSH
14. Determination of bone mineral density by quantitative computed tomography and single photon absorptiometry in subclinical hyperthyroidism: A risk of early osteopaenia in post-menopausal women
15. Long-term thyroxine treatment and bone mineral density
16. Thyroid function and bone mass in older women
17. Osteoporosis and fractures following thyrotoxicosis
18. Prevalence of fractures in postmenopausal women with thyroid disease
19. Morbidity in patients on L-thyroxine: A comparison of those with a normal TSH to those with a suppressed TSH
20. Hip fractures and the thyroid: A case-control study
21. Levothyroxine therapy and osteoporosis. An end to the controversy?
22. Thyroxine replacement therapy and circulating lipid concentrations
23. Thyroid hormone therapy and the skeleton
24. Thyroid hormone and bone mass: The clinician's dilemma
25. Hyperthyroidism, thyroid hormone therapy, and bone
26. Factors associated with appendicular bone mass in older women
27. Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis
28. Axial bone mass in older women
29. Current status and performance goals for serum thyrotropin (TSH) assays
30. Accelerated bone loss in hypothyroid patients overtreated with L-thyroxine
31. The stability of immunological and biological activity of human thyrotropin in buffer: Its temperature-dependent dissociation into subunits during freezing
32. Thyrotropin (TSH)-releasing hormone stimulation test responses employing third and fourth generation TSH assays
33. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons
34. The association of radiographically detected vertebral fractures with back pain and function: A prospective study
35. Comparison of methods for defining prevalent vertebral deformities: The Study of Osteoporotic Fractures
36. Assessing vertebral fractures
37. On the design of synthetic case-control studies
38. Analysis of case-cohort designs
39. Endogenous hormones and the risk of hip and vertebral fractures among older women
40. Effect of thyrotoxicosis and its treatment on bone mineral and muscle mass
41. Spinal bone mineral content in myxoedema and thyrotoxicosis. Effects of thyroid hormone(s) and antithyroid treatment
42. Negative correlation between the change in bone mineral density and serum osteocalcin in patients with hyperthyroidism
43. Low thyrotropin levels are not associated with bone loss in older women: A prospective study
44. Serum osteocalcin in patients taking L-thyroxine who have subclinical hyperthyroidism
45. Markers of bone resorption predict hip fracture in elderly women: The EPIDOS Prospective Study
46. Urine markers of bone resorption predict hip bone loss and fractures in older women: The Study of Osteoporotic Fractures
47. No increase in fracture incidence in patients treated for thyrotoxicosis in Malmo during 1970-74. A 20-year population-based follow-up
48. Serum sex hormone-binding globulin and osteocalcin in systemic nonthyroidal illness associated with low thyroid hormone concentrations
49. The use and limitations of a chemiluminescent thyrotropin assay as a single thyroid function test in an outpatient endocrine clinic
50. Effective laboratory evaluation of thyroid status
51. Subclinical hypothyroidism in older persons